Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Intangible Assets

$31.70M

Quarterly · Period ending: · USD

LCTX logo

LCTX Intangible Assets

Latest reported$31.70M
LCTX FY Intangible Assets ($0.00 → $31.70M)
High-resolution chart · PNG

LCTX intangible assets history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Intangible Assets — Annual fiscal periods (USD)
Period endingIntangible Assets (USD)
31,700,000
46,540,000
46,562,000
46,692,000
46,822,000
47,032,000
48,248,000
3,125,000
6,900,000
10,206,000
33,592,000
38,848,396
46,208,085
20,486,792
18,619,516
15,386,905
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.